Discovery of a novel covalent allosteric site CYS434 in Keap1 and its ligand for the treatment of acute lung injury
{{output}}
Keap1 is a central negative regulator of the Nrf2 antioxidant pathway, yet its covalent allosteric modulation remains incompletely understood. Here, we provide evidence that Cys434 may represent a previously unrecognized covalent allosteric site in Keap1. Usin... ...
